In vivo human melanoma cytokine production: Inverse correlation of GM- CSF production with tumor depth

Experimental Dermatology

Volumn 7, Issue 6, 1998, Pages 335-341

  Hensley, C ^a   Spitzler, S ^a   McAlpine, B E ^a,b   Lynn, M ^a,c   Ansel, J C ^a,b   Solomon, A R ^a,b   Armstrong, C A ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Granulocyte macrophage colony stimulating factor (GM CSF); Interleukin 8 (IL 8); Melanoma; Tumor thickness

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 8; MONOCLONAL ANTIBODY;

ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOMA; MELANOMA CELL; SKIN CANCER;

EID: 0031735790     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0625.1998.tb00333.x     Document Type: Article

References (42)

1. Slominski A, Ross J, Mihm M C. Cutaneous melanoma: pathology, relevant prognostic indicators and progression. Br Med Bull 1995: 51: 548-549.
2. Guerry D, Schuchter L M. Disseminated melanoma - is there a new standard therapy? N Engl J Med 1992: 327: 560-561.
3. Bridgewater J A, Gore M E. Biological response modifiers in melanoma. Br Med Bull 1995: 51: 656-677.
4. Anderson C M, Buzaid A C, Legha S S. Systemic treatments for advanced cutaneous melanoma. Oncology 1995: 9: 1149-1158.
5. Mukherji B, Chakraborty N. Immunobiology and immunotherapy of melanoma. Curr Opin Oncol 1995: 7: 175-184.
6. Ettinghousen S E, Rosenberg S A. Immunotherapy and gene therapy of cancer. Adv Surg 1995: 28: 223-254.
7. Maio M. Immunology of Human Melanoma: Tumor-Host Interaction and Immunotherapy. Amsterdam: IOS Press, 1996.
8. Bennicelli J L, Guerry D IV. Production of multiple cytokines by cultured human melanomas. Exp Dermatol 1993: 2: 186-190.
9. Armstrong C A, Luger T A, Ansel J C. Cytokines and malignant melanoma. In: Mukhtar H, ed. Skin cancer: mechanisms and human relevance. Boca Raton, FL: CRC Press, 1995: 273-280.
10. Armstrong C A, Tara D C, Hart C E, Köck A, Luger T C, Ansel J C. Heterogeneity of cytokine production by human malignant melanoma cells. Exp Dermatol 1992: 1: 37-45.
11. Tabibzadeh S S, Poubouridis D, May L T, Sehgal P B. Interleukin-6 immunoreactivity in human tumors. Am J Pathol 1989: 135: 427-433.
12. Tyler D S, Francis G M, Frederick M et al. Interleukin-1 production in tumor cells of human melanoma surgical specimens. J Interferon Cytokine Res 1995: 15: 331-340.
13. Armstrong C A, Murray N, Kennedy M, Koppula S V, Tara D C, Ansel J C. Melanoma-derived interleukin 6 inhibits in vivo melanoma growth. J Invest Dermatol 1994: 102: 278-284.
14. Armstrong C A, Botella R, Galloway T H et al. Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells. Cancer Res 1996: 56: 2191-2196.
15. Dranoff G, Jaffe E, Lazenby A et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long lasting anti-tumor immunity. Proc Natl Acad Sci USA 1993: 90: 3539-3543.
16. Abe J, Wakimoto H, Yoshida Y, Aoyagi M, Hirakawa K, Hamada H. Antitumor effect induced by GM-CSF gene-modified tumor vaccination: comparison of adenovirus-and retrovirus-mediated genetic transduction. J Cancer Res Clin Oncol 1995: 121: 587-592.
17. Qin H X, Charrerjee S K. Construction of recombinant vaccinia virus expressing GM-CSF and its use as tumor vaccine. Gene Ther 1996: 3: 59-66.
18. Schadendorf D, Moller A, Algermissen B, Worm M, Sticherling M, Czarnetzki B M. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol 1993: 151: 2667-2675.
19. Gutman M, Singh R K, Xie K, Bucana C D, Fidler I J. Regulation of interleukin 8 expression in human melanoma cells by the organ environment. Cancer Res 1995: 55: 2470-2475.
20. Singh R K, Gutman M, Radinsky R, Bucana C D, Fidler I J. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 1994: 54: 3242-3247.
21. Wang J M, Tarboletti G, Matsushima K, Damme J V, Mantovani A. Induction of hepatotactic migration of melanoma cells by neutrophil activating protein/IL-8. Biochem Biophys Res Comm 1990: 169: 165-170.
22. Koch A E, Polverini P J, Kunkel S L et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1994: 258: 1798-1801.
23. Singh R K, Gutman M, Reich R, Bar-Eli M. Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8. Cancer Res 1995: 55: 3669-3674.
24. Zachariae C O C, Thestrup-Pedersen K, Matsushimi K. Expression and secretion of leukocyte chemotactic cytokines by normal human melanocytes and melanoma cells. J Invest Dermatol 1991: 97: 593-599.
25. Anderson U, Anderson J. Immunolabeling of cytokine-producing cells in tissues and in suspension. In: "Cytokine Producing Cells". INSERM, Paris. 1994, 32-49.
26. Grabbe S, Bruvers S, Gallo F L, Knisely T L, Nazareno R, Granstein R D. Tumor antigen presentation by murine epidermal cells. J Immunol 1991: 146: 3656-3661.
27. Cohen P J, Cohen P A, Rosenberg S A, Katz S I, Mule J J. Murine epidermal Langerhans cells and splenic dendritic cells present tumor-associated antigens to primed T cells. Eur J Immunol 1994: 24: 315-319.
28. Shimizu J, Suda T, Yoshioka T, Kosugi A, Fujiwara H, Hamaoka T. Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen presenting cells. J Immunol 1991: 142: 1053-1059.
29. Berns A J M, Clift S, Cohen L K et al. Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma. Hum Gene Ther 1995: 6: 347-368.
30. Schadendorf D, Czarnetzki B M, Wittig B. Interleukin-7, interleukin 12, and GM-CSF gene transfer in patients with metastatic melanoma. J Mol Med 1995: 73: 473-477.
31. Chachoua A, Oratz R, Leibes L et al. Phase Ib trial of granulocyte-macrophage colony-stimulating factor combined with murine monoclonal antibody R24 in patients with metastatic melanoma. J Immunotherapy 1994: 16: 132-141.
32. Barth A, Wanek L A, Morton D L. Prognostic factors in 1521 melanoma patients with distant metastases. J Am Coll Surg 1995: 181: 193-201.
33. Day C L Jr, Mihm M C Jr, Lew R A et al. Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51-3.99 mm). A conceptual model for tumor growth and metastasis. Ann Surg 1982: 195: 35-43.
34. Schuchter L, Schultz D J, Synnestvedt M et al. A prognostic model for predicting 10-year survival in patients with primary melanoma. Ann Intern Med 1996: 125: 369-375.
35. Clark W H Jr, Elder D E, Guerry D 4th et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989: 81: 1893-1904.
36. Takahashi H, Strutton G M, Parsons P G. Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody. Histopathology 1991: 18: 221-227.
37. Vecchiato A, Rossi C R, Montesco M C et al. Proliferating cell nuclear antigen and recurrence in patients with cutaneous melonoma. Melanoma Res 1994: 4: 207-211.
38. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983: 31: 13-20.
39. Soyer H P. Ki-67 immunostaining in melanocytic skin tumors. Correlation with histologic parameters. J Cutan Pathol 1991: 18: 264-272.
40. Belle P V, Rodeck U, Nuamah I, Halpern A C, Elder D E. Melanoma-associated expression of transforming growth factor-β isoforms. Amer J Pathol 1996: 148: 1887-1894.
41. Halaban R. Growth factors and tryosine protein kinases in normal and malignant melanocytes. Cancer Metastasis Rev 1991: 10: 129-140.
42. Al-Alousi S, Barnhill R, Blessing K, Barksdale S. The prognostic significance of basic fibroblast growth factor in cutaneous malignant melanoma. J Cutan Pathol 1996: 23: 506-510.